SCHEMBL28382394

SCHEMBL28382394

O=C(Nc1cccc(C2COCCN2)c1N1CCCCC1)c1cccc(Br)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK10 P53779 4/20 0.46
▸ PIM1 P11309 1/20 0.42
▸ PIM3 Q86V86 1/20 0.42
▸ TSHR P16473 3/20 0.40
▸ ATM Q13315 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ NPSR1 Q6W5P4 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ PLA2G1B P04054 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ ATG4B Q9Y4P1 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ MAPK8 P45983 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28378617 0.88 PIM1 (0.41) MAPK10PIM1PIM3TSHRATM
SCHEMBL28378703 0.83 TSHR (0.59) MAPK10TSHRATMPOLBMAPK8
SCHEMBL28378686 0.79 CHEK1 (0.55) IRAK4
SCHEMBL28383371 0.77 PIM1 (0.55) MAPK10PIM1PIM3TSHRATM
SCHEMBL29033319 0.76 HPGD (0.42) MAPK10TSHRATMPOLBNPSR1
SCHEMBL30501501 0.68 PIM1 (0.51) PIM1PIM3TSHRNPSR1KDM4E
SCHEMBL20598735 0.68 NTRK1 (0.57) PIM1PIM3TSHRNPSR1ALDH1A1
SCHEMBL20598482 0.68 PIM1 (0.51) PIM1PIM3TSHRNPSR1KDM4E
SCHEMBL30501448 0.68 NTRK1 (0.57) PIM1PIM3TSHRNPSR1ALDH1A1
SCHEMBL20598489 0.67 IRAK4 (0.50) PIM1PIM3TSHRPOLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111032642-A Kinase inhibitors and methods of making and using 里格尔药品股份有限公司 2020-04-17 — — CN disclosed
Send feedback